These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 33345974)

  • 21. Low-dose progestin-releasing contraceptives are associated with a higher pain threshold in healthy women.
    Máximo MM; Silva PS; Vieira CS; Gonçalvez TM; Rosa-E-Silva JC; Candido-Dos-Reis FJ; Nogueira AA; Poli-Neto OB
    Fertil Steril; 2015 Nov; 104(5):1182-9. PubMed ID: 26341277
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New knowledge in the physiology of hormonal contraceptives.
    Lobo RA; Stanczyk FZ
    Am J Obstet Gynecol; 1994 May; 170(5 Pt 2):1499-507. PubMed ID: 8178898
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contraceptive implants.
    McDonald-Mosley R; Burke AE
    Semin Reprod Med; 2010 Mar; 28(2):110-7. PubMed ID: 20352560
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prospective multicentre study comparing levonorgestrel implants with a combined contraceptive pill: final results.
    Kirkman RJ; Bromham DR; O'Connor TP; Sahota JE
    Br J Fam Plann; 1999 Jul; 25(2):36-40. PubMed ID: 10454652
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Subdermal contraceptive implants.
    Peralta O; Diaz S; Croxatto H
    J Steroid Biochem Mol Biol; 1995 Jun; 53(1-6):223-6. PubMed ID: 7626459
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Contraceptives as possible risk factors for postpartum depression: A retrospective study of the food and drug administration adverse event reporting system, 2004-2015.
    Horibe M; Hane Y; Abe J; Matsui T; Kato Y; Ueda N; Sasaoka S; Motooka Y; Hatahira H; Hasegawa S; Kinosada Y; Hara H; Nakamura M
    Nurs Open; 2018 Apr; 5(2):131-138. PubMed ID: 29599988
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combined hormonal versus nonhormonal versus progestin-only contraception in lactation.
    Lopez LM; Grey TW; Stuebe AM; Chen M; Truitt ST; Gallo MF
    Cochrane Database Syst Rev; 2015 Mar; 2015(3):CD003988. PubMed ID: 25793657
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Real-world cost-effectiveness of etonogestrel implants compared to long-term and short term reversible contraceptive methods in France.
    Linet T; Lévy-Bachelot L; Farge G; Crespi S; Yang JZ; Robert J; Fabron C
    Eur J Contracept Reprod Health Care; 2021 Aug; 26(4):303-311. PubMed ID: 33960248
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of Implanon on lipid metabolism in comparison with Norplant.
    Suherman SK; Affandi B; Korver T
    Contraception; 1999 Nov; 60(5):281-7. PubMed ID: 10717780
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Newer non-oral hormonal contraception.
    Bateson D; McNamee K; Briggs P
    BMJ; 2013 Feb; 346():f341. PubMed ID: 23412438
    [No Abstract]   [Full Text] [Related]  

  • 31. Two oral contraceptives, efficacy, serum proteins, and lipid metabolism. A comparative multicentre study on a triphasic and a fixed dose combination.
    Cullberg G; Samsioe G; Andersen RF; Bredesgaard P; Andersen NB; Ernerot H; Fanøe E; Fylling P; Haack-Sørensen PE; Klottrup P; Pedersen JH; Sandager T
    Contraception; 1982 Sep; 26(3):229-43. PubMed ID: 6217028
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationships between blood pressure, oral contraceptive use and metabolic risk markers for cardiovascular disease.
    Godsland IF; Crook D; Devenport M; Wynn V
    Contraception; 1995 Sep; 52(3):143-9. PubMed ID: 7587185
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Safety profile of etonogestrel contraceptive implant (Nexplanon
    Simon C; Agier MS; Béné J; Muller C; Vrignaud L; Marret H; Jonville-Bera AP
    J Gynecol Obstet Biol Reprod (Paris); 2016 Nov; 45(9):1074-1082. PubMed ID: 27125380
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Two-year continuation of intrauterine devices and contraceptive implants in a mixed-payer setting: a retrospective review.
    Sanders JN; Turok DK; Gawron LM; Law A; Wen L; Lynen R
    Am J Obstet Gynecol; 2017 Jun; 216(6):590.e1-590.e8. PubMed ID: 28188772
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Steroidal contraceptives: effect on carbohydrate metabolism in women without diabetes mellitus.
    Lopez LM; Grimes DA; Schulz KF
    Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31711271
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insulin resistance, secretion, and metabolism in users of oral contraceptives.
    Godsland IF; Walton C; Felton C; Proudler A; Patel A; Wynn V
    J Clin Endocrinol Metab; 1992 Jan; 74(1):64-70. PubMed ID: 1530790
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differences in prescription rates and odds ratios of antidepressant drugs in relation to individual hormonal contraceptives: a nationwide population-based study with age-specific analyses.
    Lindberg M; Foldemo A; Josefsson A; Wiréhn AB
    Eur J Contracept Reprod Health Care; 2012 Apr; 17(2):106-18. PubMed ID: 22385398
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Levonorgestrel subdermal implants. Contraception on trial.
    Frank ML; DiMaria C
    Drug Saf; 1997 Dec; 17(6):360-8. PubMed ID: 9429835
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hormonal and intrauterine methods for contraception for women aged 25 years and younger.
    Tang JH; Lopez LM; Mody S; Grimes DA
    Cochrane Database Syst Rev; 2012 Nov; 11():CD009805. PubMed ID: 23152281
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Subdermal implantable contraceptives versus other forms of reversible contraceptives or other implants as effective methods of preventing pregnancy.
    Power J; French R; Cowan F
    Cochrane Database Syst Rev; 2007 Jul; 2007(3):CD001326. PubMed ID: 17636668
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.